The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Young, S R ^a   Pilarski, Robert T ^b   Donenberg, Talia ^c   Shapiro, Charles ^b   Hammond, Lyn S ^d   Miller, Judith ^e   Brooks, Karen A ^a   Cohen, Stephanie ^f   Tenenholz, Beverly ^g   DeSai, Damini ^h   Zandvakili, Inuk ⁱ   Royer, Robert ⁱ   Li, Song ⁱ   Narod, Steven A ⁱ  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c University of Miami Jackson Memorial Medical Center   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f ST VINCENT HOSPITAL   (United States)

^g GEISINGER MEDICAL CENTER   (United States)

^h Joe Arrington Cancer Center   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER SCREENING; DENATURING GRADIENT GEL ELECTROPHORESIS; EXON; FAMILY HISTORY; FEMALE; FLUORESCENCE ANALYSIS; GENE DELETION; GENE DUPLICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; ONSET AGE; PREVALENCE; RISK ASSESSMENT; SEQUENCE ANALYSIS; BREAST TUMOR; GENE FREQUENCY; GENETIC SCREENING; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC SCREENING; HUMANS; MUTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 64749086562     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-86     Document Type: Article

References (20)

1. Narod SA Foulkes WD BRCA1 and BRCA2: 1994 and beyond Nature Rev Cancer 2004, 4:665-76. 10.1038/nrc1431
2. Warner E Foulkes W Goodwin P Meschino W Blondal J Paterson C Ozcelik H Goss P Allingham-Hawkins D Hamel N Di Prospero L Contiga V Serruya C Klein M Moslehi R Honeyford J Liede A Glendon G Brunet JS Narod S Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 1999, 91:1241-7. 10.1093/jnci/91.14.1241 10413426
3. Tonin PN Mes-Masson AM Futreal PA Morgan K Mahon M Foulkes WD Cole DE Provencher D Ghadirian P Narod SA Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families Am J Hum Genet 1998, 63:1341-51. 1377544 9792861 10.1086/302099
4. Górski B Byrski T Huzarski T Jakubowska A Menkiszak J Gronwald J Pluzañska A Bebenek M Fischer-Maliszewska L Grzybowska E Narod SA Lubinski J Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer Am J Hum Genet 2000, 66:1963-8. 1378051 10788334 10.1086/302922
5. Euhus DM Smith KC Robinson L Stucky A Olopade OI Cummings S Garber JE Chittenden A Mills GB Rieger P Esserman L Crawford B Hughes KS Roche CA Ganz PA Seldon J Fabian CJ Klemp J Tomlinson G Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO J Natl Cancer Inst 2002, 94:844-51. 12048272
6. Antoniou AC Pharoah PP Smith P Easton DF The BOADICEA model of genetic susceptibility to breast and ovarian cancer Brit J Cancer 2004, 91:1580-1590. 15381934
7. Foulkes WD Stefansson IM Chappuis PO Bégin LR Goffin JR Wong N Trudel M Akslen LA Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 2003, 95:1482-5. 14519755
8. Lakhani SR Reis-Filho JS Fulford L Penault-Llorca F Vijver van der M Parry S Bishop T Benitez J Rivas C Bignon YJ Chang-Claude J Hamann U Cornelisse CJ Devilee P Beckmann MW Nestle-Krämling C Daly PA Haites N Varley J Lalloo F Evans G Maugard C Meijers-Heijboer H Klijn JG Olah E Gusterson BA Pilotti S Radice P Scherneck S Sobol H Jacquemier J Wagner T Peto J Stratton MR McGuffog L Easton DF Breast Cancer Linkage Consortium Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 2005, 11:5175-80. 10.1158/1078-0432.CCR-04-2424 16033833
9. Foulkes WD Metcalfe K Sun P Hanna WM Lynch HT Ghadirian P Tung N Olopade OI Weber BL McLennan J Olivotto IA Bégin LR Narod SA Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: The influence of age, grade, and histological type Clin Cancer Res 2004, 10:2029-34. 10.1158/1078-0432.CCR-03-1061 15041722
10. Dent R Trudeau M Pritchard KI Hanna WM Kahn HK Sawka CA Lickley LA Rawlinson E Sun P Narod SA Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Re 2207, 13:4429-34. 10.1158/1078-0432.CCR-06-3045
11. Kuperstein G Foulkes WD Ghadirian P Hakimi J Narod SA A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes Clin Genet 2000, 57:213-20. 10.1034/ j.1399-0004.2000.570307.x 10782928
12. The BRCA1 Exon 13 Duplication Screening Group The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. the BRCA1 exon 13 duplication screening group Am J Hum Genet 2000, 67:207-12. 1287079 10827109 10.1086/302974
13. Zhang S Kuperstein G Narod SA Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): Detecting mutations in the BRCA1 gene Nat Protoc 2006, 1:3101-10. 10.1038/ nprot.2006.445 17406573
14. ASCO Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility J Clin Oncol 1996, 14:1730-6. 8622094
15. Lidereau R Eisinger F Champème MH Noguès C Bièche I Birnbaum D Pallud C Jacquemier J Sobol H Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer Cancer Res 2000, 60:1206-10. 10728676
16. Peto J Collins N Barfoot R Seal S Warren W Rahman N Easton DF Evans C Deacon J Stratton MR Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 1999, 91:943-9. 10.1093/jnci/91.11.943 10359546
17. Chang J Hilsenbeck SG Sng JH Wong J Ragu GC Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients Clin Cancer Res 2001, 7:1739-42. 11410514
18. Haffty BG Yang Q Reiss M Kearney T Higgins SA Weidhaas J Harris L Hait W Toppmeyer D Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 2006, 24:5652-7. 10.1200/JCO.2006.06.5664 17116942
19. Farshid G Balleine RL Cummings M Waring P Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab) Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing Am J Surg Pathol 2006, 30:1357-66. 10.1097/01.pas.0000213273.22844.1a 17063074
20. Gusterson BA Ross DT Heath VJ Stein T Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer Breast Cancer Res 2005, 7:143-8. 1175069 15987465 10.1186/ bcr1041